Apures's latest marketcap:
As of 06/06/2025, Apures's market capitalization has reached $2.32 M. According to our data, Apures is the 45682th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.32 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 45.49 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Apures's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₩3.18 B | -62.24% |
| 12/30/2024 | ₩8.43 B | -32.29% |
| 12/28/2023 | ₩12.45 B | -58.23% |
| 12/29/2022 | ₩29.82 B | -55.02% |
| 12/30/2021 | ₩66.29 B | -15.4% |
| 12/30/2020 | ₩78.35 B |
Company Profile
About Apures Co., Ltd.
Apures Co., Ltd. is a South Korean company specializing in innovative bio and medical solutions. Founded in 2001 and headquartered in Pyeongtaek-si, the company focuses on advancing research and treatments in regenerative medicine and biomaterials.
Core Offerings
- MICROPIG Development: Specializes in research and laboratory mini pig species, providing standardized biomaterials for medical experiments and regenerative medicine, including cell therapy and heterogeneous organ development.
- Porcine Primary Cell: Supplies in vitro testing solutions using porcine cells.
- Heterogeneous Organ Technology: Develops and transplants animal tissues and organs as alternatives for human applications.
- Bio Membrane (FCM Brand): Manufactures research skin products for in vitro testing.
- CRO Services: Offers contract research organization services to support medical and scientific research.
Company Background
Originally established as MediKinetics Co., Ltd., the company rebranded to Apures Co., Ltd. in 2019. Since its inception, Apures has been at the forefront of bio-innovation, contributing to advancements in medical research and therapeutic solutions.
Frequently Asked Questions
-
What is Apures's (XKON-149300) current market cap?As of 06/06/2025, Apures (including the parent company, if applicable) has an estimated market capitalization of $2.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Apures (XKON-149300) rank globally by market cap?Apures global market capitalization ranking is approximately 45682 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.